1. Barrington J.W., Lindsay P., James D., et al.: Selenium deficiency and miscarriage: a possible link? Br. J. Obstet. Gynaecol., 1996, 103, 130.
2. Brozowska A.: Składniki mineralne. W: Żywienie człowieka. Podstawy nauki o żywieniu. J. Gawęcki, L. Hryniewiecki (red.): Warszawa, Wydawnictwo Naukowe PZWL 1998, 189.
3. Duffield-Lillico A.J., Dalkin B.L., Reid M.E., et al.: Selenium supplementation, baseline plasma selenium status and incidence of prostate cancer: an analysis of the complete treatment period of the Nutritional Prevention of Cancer Trial. Brit. J. Urol., 2003, 91, 608.
4. Duffield-Lillico A.J., Slate E.H., Reid M.E., et al.: Selenium supplementation and secondary prevention of nonmelanoma skin cancer in a randomized trial. J. Nutr. Cancer Inst. 2003, 95, 1477.
5. Flohe L.: Selenium, Selenoproteins and vision. In: Nutrition and the eye. A.J. Augustin (ed.): Karger 2005, 89.
6. Garland M., Morris J.S., Stampfer M.J., et al.: Prospective study of toenail selenium levels and cancer among woman. J. Natl. Cancer Inst. 1995, 87, 497.
7. Ghadirian P., Maisonneuve P., Perret C., et al.: A case-control study of toenail selenium and cancer of the breast, colon and prostate. Cancer. Detect. Prev., 2000, 24, 305.
8. Iwanier K., Zachara B.A.: Selenium supplementation enhances the element concentration in blood and seminal fluid but does not change the spermatozoal quality characteristics in subfertile men. J. Androl., 1995, 16, 441.
9. Kardinaal A.F., Kok F.J., Kohlmeier L., et al.: Association between toenail selenium and risk of acute miocardial infarction in European men. The EURAMIC Study. Am. J. Epidemiol., 1997, 145, 373.
10. Kiremidjian-Schumacher L., Roy M., Wishe H.I., et al.: Supplementation with selenium augments the function of natural killer and limphokine-activated killer cells. Biol. Trace. Elem. Res. 1996, 52, 227.
11. Kiremidjian-Schumacher L., Roy M., Wishe H.I., et al.: Supplementation with selenium and human immune cell function. II. Effect on lymphocytes and natural killer cells. Biol. Trace Elem. Res. 1994, 41, 115.
12. Knekt P., Marniemi J., Teppo L., et al.: Is low selenium status a risk factor for lung cancer? Am. J. Epidemiol., 1998, 148, 975.
13. Lipsky K., Zigeuner R., Zischka M., et al.: Selenium levels of patients with newly diagnosed prostate cancer compared with control group. Urology 2004, 63, 912.
14. Oldereid N.B., Thomassen Y., Purvis K.: Selenium in human male reproductive organs. Human Reproduction 1998, 13, 2172.
15. Patrick L.: Selenium biochemistry and cancer: a review of the literature. Altern. Med. Rev., 2004, 9, 239.
16. Reid M.E., Duffield-Lillico A.J., Garland L., et al.: Selenium supplementation and lung cancer incidence: an update of the nutritional prevention of cancer trial. Cancer Epidemiol. Biomarkers Prev., 2002, 11, 1285.
17. Rayman M.P.: The importance of selenium to human health. Lancet 2000, 356, 233.
18. Roy M., Kiremidjian-Schumacher L., Wishe H.I., et al.: Supplementation with selenium and human immune cell function. I. Effect on limphocyte proliferation and interleukin 2-receptor expression. Biol. Trace Elem. Res. 1994, 41, 103.
19. Salonen J.T., Alfthan G., Huttunen J.K., et al.: Association between cardiovascular death and miocardial infarction and serum selenium in matched-pair longitudinal study. Lancet 1982, 8291, 175.
20. Salonen J.T., Alfthan G., Huttunen J.K., et al.: Association between serum selenium and the risk of cancer. Am. J. Epidemiol., 1984, 120, 342. (abstr.).
21. Salvini S., Hennekens C.H., Morris J.S., et al.: Plasma levels of the antioxidant selenium and risk of miocardial infarction among U.S. physicians. Am. J. Cardiol., 1995, 76, 1218.
22. Scott R., MacPherson A., Yates R.W., et al.: The effect of oral selenium supplementation on human sperm motility. Brit. J. Urol., 1998, 82, 76.
23. Sher L.: Role of selenium depletion in the etiopathogenesis of depression in patient with alcoholism. Medical Hypotheses 2002, 59, 330.
24. Shreier P.: Chemopreventive compounds in the diet. In: Nutrition and the eye. A.J. Augustin (ed.): Karger, 2005, 16.
25. Suadicani P, Hein H.O., Gyntelberg F.: Serum selenium and risk of ischaemic heart disease in a prospective cohort study of 3000 males. Atherosclerosis 1992, 96, 33.
26. Virtamo J., Velkeila E., Alfthan G., et al.: Serum selenium and the risk of coronary heart disease and stroke. Am. J. Epidemiol., 1985, 122, 246.
27. Wasowicz W., Gromadzińska J., Rydzyński K., et al.: Selenium status of low-selenium area residents: Polish experience. Toxicol. Lett., 2003, 137, 95.
28. Yoshizawa K., Ascherio A., Morris J.S., et al.: Prospective study of selenium levels in toenails and risk of coronary heart disease in man. Am. J. Epidemiol., 2003, 158, 852.
29. Yu S.Y., Zhu Y.J., Li W.G.: Protective role of selenium against hepatitis B virus and primary liver cancer in Qidong. Biol. Trace Elem. Res., 1997, 56, 117.
30. Yu M.W., Horng I.S., Hsu K.H., et al.: Plasma selenium levels and risk of hepatocellular carcinoma among men with chronic hepatitis virus infection. Am. J. Epidemiol., 1999, 150, 367- 29.